NCT07868185

Brief Summary

This research explores General Movements (GMs) in a reference population. Abnormal general movements in babies are predictive of autism spectrum disorders or neurodevelopmental deficits. General movements have received little attention in the context of foetuses, which is why developing a reading grid to analyse general movements in foetuses could be a valuable tool for facilitating early diagnosis and prompt treatment of at-risk babies.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
29mo left

Started Feb 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
Feb 2023Feb 2029

Study Start

First participant enrolled

February 14, 2023

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

April 27, 2026

Completed
6 months until next milestone

First Posted

Study publicly available on registry

October 9, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 14, 2027

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 14, 2029

Last Updated

October 9, 2026

Status Verified

October 1, 2026

Enrollment Period

4 years

First QC Date

April 27, 2026

Last Update Submit

October 5, 2026

Conditions

Keywords

Ultrasound recordingsGeneral Movements GridAutism spectrum disorders in the foetusNeurodevelopmental deficits in the foetus

Outcome Measures

Primary Outcomes (1)

  • Quantitative and Qualitative Parameters of General Fetal Movements Assessed by Ultrasound Recordings Across Gestation

    Presence, frequency, and characteristics of abnormal fetal movement patterns identified on ultrasound recordings obtained at 13, 17, 23, and 33 weeks of amenorrhea (±10 days). Recordings will be independently assessed by experts in fetal ultrasonography and General Movements Assessment using the General Movements Assessment grid adapted for preterm infants. Reported outcomes will include the occurrence and type of abnormal movement patterns at each assessment time point.

    9 months

Secondary Outcomes (2)

  • General Movement Patterns at 0 to 4 Weeks and 11 to 16 Weeks After Birth Assessed From Video Recordings

    Week 4 and week 16

  • Child Development Scores Assessed by Pediatric Developmental Questionnaires at 12 and 24 Months of Age

    Year 1 and year 2

Study Arms (1)

Pregnant women treated in the gynaecology-obstetrics department

EXPERIMENTAL

In addition to the standard follow-up ultrasound, pregnant participants treated in the gynaecology-obstetrics department, will be offered a research-specific endovaginal or external ultrasound at 13, 17 (if an amniocentesis is performed), 23 and 33 weeks of amenorrhoea (±10 days). On average, 10% of ultrasounds are endovaginal and 90% are external.

Procedure: External or endovaginal ultrasound

Interventions

Endovaginal or external ultrasound specifically for research at 13, 17 (if amniocentesis), 23 and 33 weeks of amenorrhoea (+/- 10 days) (on average 10% endovaginal / 90% external ultrasound). Each patient will undergo one to four additional ultrasound scans.

Pregnant women treated in the gynaecology-obstetrics department

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient aged over 18
  • Pregnant from 13 weeks of amenorrhoea
  • Indication for an ultrasound scan as part of the usual monitoring of her pregnancy
  • With no particular history or who has had a child with autism spectrum disorders or neurodevelopmental disorders
  • Able to understand the benefits and constraints of the research
  • Having given signed consent to participate, as well as that of his/her spouse.
  • Beneficiary of a social security scheme or entitled person (excluding AME).

You may not qualify if:

  • Pathological pregnancy
  • Under guardianship, curatorship or legal protection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groupe Hospitalier Diaconesses Croix Saint-Simon

Paris, Paris, 75012, France

RECRUITING

Central Study Contacts

Djazia Bouzelmat, Clinical Research Assistant

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
gynaecologist

Study Record Dates

First Submitted

April 27, 2026

First Posted

October 9, 2026

Study Start

February 14, 2023

Primary Completion (Estimated)

February 14, 2027

Study Completion (Estimated)

February 14, 2029

Last Updated

October 9, 2026

Record last verified: 2026-10

Locations